Caroline Pabst, M.D.1,2*, Anne Bergeron, PhD3*, Vincent-Philippe Lavallée, M.D.4, Jonathan Yeh, PhD5*, Patrick Gendron, M.Sc2*, Jana Krosl, PhD6*, Geneviève Boucher, M.Sc2*, Sébastien Lemieux, Ph.D.2,7*, Josee Hébert, MD8,9,10,11, Guy Sauvageau, M.D., Ph.D.2,9,12 and Frédéric Barabé, MD13,14,15
1Martin-Luther-University of Halle-Wittenberg, Department of Internal Medicine IV- Hematology and Oncology, Halle (Saale), Germany
2The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
3Centre de Recherche du CHU de Québec, Centre de Recherche en Infectiologie, Quebec City, Canada
4Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada
5University of Montreal, Institute for Research in Immunology and Cancer, Montreal, Canada
6IRIC/Unv. de Montreal Faculty of Medicine, Montreal, QC, Canada
7Department of Computer Science and Operations Research, Université de Montréal, Montréal, QC, Canada
8Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
9Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada
10Hematology-Oncology Division, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
11Quebec Leukemia Cell Bank, Montréal, QC, Canada
12Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
13Centre de Recherche du CHU de Québec, Centre de Recherche en Infectiologie, Québec, Canada
14CHU de Québec, Hopital Enfant-Jésus, Québec, Canada
15Department of Medicine, Université Laval, Québec, Canada